Product Images Valsartan And Hydrochlorothiazide

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Valsartan And Hydrochlorothiazide NDC 63629-5271 by Bryant Ranch Prepack, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

lbl636295271

lbl636295271

This appears to be a label of medication named Valsartan/Hctz HEDOWAL LB, packaged by Bryant Ranch Prepack Burkbank. The medication contains 160mg/12.5mg of the substance and the tablet is suggested to be kept tightly closed. It is advised to be stored at a room temperature of 20 - 25°C. This medication is compared to another medication, and it is suggested to be stored for a specific duration. Lastly, the label provides a National Drug Code (NDC) starting with 636295.*

Figure 1: Probability of Achieving Systolic Blood Pressure <140 mmHg at Week 8 - valhyctz fig1

Figure 1: Probability of Achieving Systolic Blood Pressure <140 mmHg at Week 8 - valhyctz fig1

This is a graph depicting the probability of achieving a systolic blood pressure of less than 140 mmHg at week 8. The graph shows the baseline SBP range from 145 to 180 mmHg. The medications shown are Valsartan and Hydrochlorothiazide at a dosage of 320 mg/25 mg and Valsartan alone at a dosage of 320 mg along with a placebo. The numbers "2883223288" and "140" do not provide any useful information in this context.*

Figure 2: Probability of Achieving Diastolic Blood Pressure <90 mmHg at Week 8 - valhyctz fig2

Figure 2: Probability of Achieving Diastolic Blood Pressure <90 mmHg at Week 8 - valhyctz fig2

This is a figure that shows the probability of achieving a diastolic blood pressure (DBP) of less than 90 mmHg at week 8. The figure includes a baseline DBP measurement and three additional DBP measurements of 100, 95, and 105 mmHg.*

Figure 3: Probability of Achieving Systolic Blood Pressure <130 mmHg at Week 8 - valhyctz fig3

Figure 3: Probability of Achieving Systolic Blood Pressure <130 mmHg at Week 8 - valhyctz fig3

This is a figure illustrating the probability of achieving systolic blood pressure below 130 mmHg at week 8. The figure includes treatment options of Valsartan and Hydrochlorothiazide at 320 mg /25 mg, Valsartan at 320 mg, and a placebo. The baseline systolic blood pressure is measured in mmHg from 140 to 180.*

Figure 4: Probability of Achieving Diastolic Blood Pressure <80 mmHg at Week 8 - valhyctz fig4

Figure 4: Probability of Achieving Diastolic Blood Pressure <80 mmHg at Week 8 - valhyctz fig4

This is a graph showing the probability of achieving diastolic blood pressure of less than 80 mmHg at week 8 for patients treated with Valsartan and Hydrochlorothiazide 320 mg/25 mg, as compared to a placebo. The baseline diastolic blood pressure was measured between 95-110 mmHg.*

Valsartan Chemical Structure - valhyctz str1

Valsartan Chemical Structure - valhyctz str1

Hydrochlorothiazide Chemical Structure - valhyctz str2

Hydrochlorothiazide Chemical Structure - valhyctz str2

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.